Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes
NCT05890950Phase 1Completed
- Sponsor
- Kallyope
- Start
- Mar 2023
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
Phase 1, randomised trial in obesity and type 2 diabetes mellitus (T2DM), sponsored by Kallyope. Primary endpoints: Proportion of participants who experienced 1 or more treatment-emergent AEs at 28 days, Proportion of participants who discontinued study medication due to an AE at 28 days and 1 more. Started Mar 2023; status: completed.
02
Conditions
obesitytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05890950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05890950.